← Back
$AMLX All transactions

Amylyx Pharmaceuticals, Inc.

M

$ Value

$0

Shares

197,153

Price

$0

Filed

Jan 20

Insider

Name

Klee Justin B.

Title

Co-Chief Executive Officer

CIK

0001898314

Roles

Director Officer

Transaction Details

Transaction Date

2026-01-15

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

2,847

Footnotes

Reflects shares sold to cover option cost and tax obligations upon the option exercise pursuant to a preset sales plan adopted by the reporting person on November 12, 2025. | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.26 to $13.77. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. | The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.83 to $13.91. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. | This option is fully vested and exercisable. The option is due to expire on February 19, 2026.

Filing Info

Accession No.

0001193125-26-017056

Form Type

4

Issuer CIK

0001658551

Klee Justin B.'s History

Date Ticker Type Value
2026-03-05 AMLX A $0
2026-03-05 AMLX A $0
2026-03-02 AMLX $424K
2026-02-02 AMLX $228K
2026-01-16 AMLX M $22K
2026-01-16 AMLX $28K
2026-01-16 AMLX M $0
2026-01-15 AMLX M $1.5M
2026-01-15 AMLX $1.8M
2026-01-15 AMLX M $0

Other Insiders at AMLX (90d)

Insider Bought Sold Last
FRATES JAMES M
Chief Financial Officer
$167K 2026-03-05
Bedrosian Camille L
Chief Medical Officer
$94K 2026-03-05
Klee Justin B.
Co-Chief Executive Officer
$651K 2026-03-05
Cohen Joshua B
Co-Chief Executive Officer
$652K 2026-03-05
Mazzariello Gina
Chief Legal Officer
$198K 2026-03-05